Assessed contributions

Assessed contributions

WHO/S. Liste
© Credits

Assessed contributions (AC) are the amounts each of the 196 Members and Associate Members must pay to WHO on an annual basis. The assessment scale is calculated by the United Nations based mainly on the country’s GDP and is adjusted for WHO’s membership. It is approved every two years by the World Health Assembly (refer to the latest approved assessment scale resolution attached here).  

Assessed contributions are a key source of financing for the Organization, providing predictable financing, helping to minimize the dependence on a narrow donor base, and allowing resources to be aligned to the Programme Budget.  Assessed contributions have declined as an overall percentage of the Programme Budget and have, for several years, accounted for less than 20% of the Organization’s financing. The balance is mobilized through voluntary contributions.

Notice of Assessments and Statements of Account

All →

Click the All button to search for the latest Notice of Assessment and Individual Statements of Account by Member State and by year. Notice of assessments are available for each biennium, please select 2020 as dropdown filter.

End-of year holiday season may affect the surveillance testing and reporting practices in one or more regions. Globally, influenza activity was elevated...

PCVA manual

This manual provides comprehensive guidance for physicians on certifying and coding causes of death from verbal autopsy (VA) data, covering VA principles,...

Icons ATC Executive

All new temporary ATC codes and alterations are published at the ATC/DDD Centre’s website and in WHO Drug Information .  

Icons INN Executive Summary

During the 81st INN Consultation, 281 INN requests were discussed, including:• 244 new INN requests, of which 136 were for biological substances•...

The Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003 to provide independent, authoritative, scientific advice to WHO...

Updated January 2026.WHO seeks to provide timely access to affordable, quality pharmaceutical products in accordance with the WHO Quality Assurance Policy...

The update charts progress achieved by the TB Vaccine Accelerator Council and its Secretariat between March and December 2025.